mahatmapaul
1 month ago
"looking good ...."
this screams for a Devil's Advocate response.
What is looking good in this latest PR? They're talking about filing certain "patent pending" applications (or whatever the term is for patents that have been filed but not accepted yet) internationally. I took a look at the description, and i'm having a hard time figuring out what's patentable in the process they describe.
The key innovation provided by these patents is the introduction of a new "first-person view" to the surgical theatre. This technology integrates cameras directly into surgical tools in order to allow the surgeon to follow and perform the procedure from his tool's perspective.
If anyone can explain how this process could be patentable, I'm all ears.
O'Shea promised again (earlier this year) that Africa would be producing revenues by the end of 2024. Let's hold O'Shea's feet to the fire on this one. For years now, the pro-O'Shea'rs have been letting him promise and not deliver ... promise and not deliver ... What the pro-O'Shea'rs need to realize is that criticism of management is a key element in DD-based investing. Somehow, there seems to be a class of investors who consider criticism of management off-limits. Why? We're in otc pinky land, and the refusal to consider criticizing management could be catastrophic to one's finances. .0175 pps indicates market's lack of confidence. Don't get mad at the market, or at weird posters posting negatives on a message board that perhaps a dozen boneheads (myself included) read. Get concerned about managements consistent failure to meet promised and forecast deadlines.
AveragePenny
1 month ago
$XCRT Xcelerate, Inc. Announces Commencement of the Nationalization Process for its PCT International Patent Applications
https://www.accesswire.com/905830/xcelerate-inc-announces-commencement-of-the-nationalization-process-for-its-pct-international-patent-applications
MAULDIN, SC / ACCESSWIRE / August 22, 2024 / Xcelerate, Inc. (OTCQB:"XCRT") today announced the commencement of the nationalization process for its two PCT international patent applications, PCT/US2023/015755 and PCT/US2023/016194. These international patents correspond to the US utility patent applications US 18/187,352 and US 18/189,441 filed with the United States Patent and Trademark Office (USPTO). The key innovation provided by these patents is the introduction of a new "first-person view" to the surgical theatre. This technology integrates cameras directly into surgical tools in order to allow the surgeon to follow and perform the procedure from his tool's perspective. We believe this introduction of the "first-person view" has the potential to significantly boost the precision and speed of a surgical procedure, as well as reducing the size of the surgical site. As an additional potential benefit, the technology integrates surgical site illumination and allows for the projection of targeting markers.
Mike O'Shea, Xcelerate's CEO stated "In addition to our efforts to uplist our common stock for listing on Nasdaq, we are also focusing on the nationalization of our medical device patents. The nationalization of these patents is a significant advancement in Xcelerate's mission to leverage non-medical engineering advancements and intellectual property for clinical and medical care. Mr. O'Shea continued by stating "We are looking forward to using the European Unitary Patent Application Process for the first time. Unitary Patent Applications have been possible since June 2023 and allow filers to cover 17 member states of the European Union (EU) with a single application. This includes the EU's three largest economies: Germany, France, and Italy. Other markets which will be covered include China, Ireland, Japan, and Mexico."